Osteosarcoma in Pre-adolescent Patients
Authors:
Open Access
- 1 November 2006
- journal article
- research article
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 34 (6) , 676-681
Abstract
The medical records of 38 pre-adolescent (aged ≤ 10 years) and 43 adolescent (aged 11-15 years) patients with primary osteosarcoma treated using the same protocol were reviewed in order to determine whether the clinical features and prognosis differed between these two groups. Gender, tumour location, tumour size, serum levels of alkaline phosphatase and lactic dehydrogenase before treatment, and chemotherapy-induced tumour necrosis were recorded, together with survival data. These parameters were compared in the two groups, and their prognostic significance was evaluated in the pre-adolescent patients. There were no statistically significant differences in the clinical parameters between pre-adolescent and adolescent patients. Only a poor level of chemotherapy-induced tumour necrosis was significantly associated with a poor prognosis in pre-adolescent patients. This study indicates that osteosarcoma behaviour is similar in pre-adolescent and adolescent patients, and there appears to be little justification for adopting different therapies in these two groups.Keywords
This publication has 22 references indexed in Scilit:
- Primary High-Grade OsteosarcomaJournal of Pediatric Hematology/Oncology, 2005
- Advances in the Diagnosis and Treatment of NeuroblastomaThe Oncologist, 2003
- Osteosarcoma in Preadolescent PatientsClinical Orthopaedics and Related Research, 2000
- The impact of age on outcome in lymphoblastic leukaemia; MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working PartiesLeukemia, 1998
- Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group.Journal of Clinical Oncology, 1997
- Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response.Journal of Clinical Oncology, 1988
- Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study.Journal of Clinical Oncology, 1984
- Adjuvant chemotherapy in nonmetastatic osteosarcoma: A southwest oncology group studyMedical and Pediatric Oncology, 1980
- Osteosarcoma of bone and its important recognizable varietiesAmerican Journal of Surgical Pathology, 1977
- Prognostic factors in osteosarcoma: A review of 20 years' experience at the university of pittsburgh health center hospitalsCancer, 1975